National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs.

Abstract

The incremental healthcare and MPL costs of preventable ADEs resulting from inpatient injectable medications are substantial. The data in this study strongly support the clinical and business cases of investing in efforts to prevent errors related to injectable medications.